Please login to the form below

Not currently logged in
Email:
Password:

ABPI backs INFORCE

The Association of the British Pharmaceutical Industry has announced the launch of a new project in Nottingham to improve the treatment of chronic obstructive pulmonary disease
The Association of the British Pharmaceutical Industry (ABPI) has announced the launch of a new project in Nottingham to improve the treatment of chronic obstructive pulmonary disease (COPD).

Industry and Nottingham NHS Focus on Reducing COPD Exacerbations (INFORCE), is aimed at alleviating the burden on the health service created by the disease. It is a collaborative effort between Nottingham Primary Care Trust, Nottingham University Hospitals NHS Trust and five pharmaceutical companies operating under the banner of the ABPI NHS Outreach Programme.

"We all have a shared interest in improving people's health and reducing their need for hospital treatment," said Jan Balmer, regional facilitator for the ABPI. "The pharmaceutical industry is committed to working with the NHS throughout the UK to identify and develop similar opportunities where we can benefit patients by sharing our skills, experience and resources."

COPD affects approximately 3.7 million people in the UK and claims 140 lives every year in Nottingham alone. Although there are about 1,000 hospital admissions in the city per year, some of these are for repeat treatments.

It is hoped that INFORCE will reduce the number of people being admitted to hospital with COPD, the generic name for conditions, such as emphysema and chronic asthma, which cause obstruction of the airways.

"This is an excellent scheme which cuts across organisational boundaries to provide better care for patients," said Dr Johnathan Corne, consultant physician at Nottingham University Hospitals. "I am confident the outcomes of this scheme will help us to improve care of people with COPD and reduce the number of unnecessary admissions to hospital."

This is the second joint scheme the ABPI has embarked on in Nottingham, the first being Happy Hearts, a cardiovascular disease management project.

29th May 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
PharmiWeb Solutions

PharmiWeb Solutions creates, delivers and manages digital solutions for the pharmaceutical and healthcare segment. From digital marketing, to patient education...

Latest intelligence

ema1
The European Medicines Agency: PRIME’d for access?
Leela Barham examines the impact of the EMA's PRIME fast track system after two years...
How can pharma engage with key stakeholders on NHS service transformation?
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare consulting team, explain how pharma should make its case for change...
michael elliot
The race for an HIV ‘cure’
Supercharging therapies as pharma and patients work together...

Infographics